James E Flynn Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of James E Flynn for June 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.24 | 79,586 | 178,098 | 6,853,826 | 6.9 M to 6.9 M (-1.15 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.24 | 101,291 | 226,669 | 8,723,052 | 8.8 M to 8.7 M (-1.15 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.24 | 33,627 | 75,251 | 3,518,297 | 3.6 M to 3.5 M (-0.95 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 38,598 | 86,876 | 6,933,412 | 7 M to 6.9 M (-0.55 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 49,124 | 110,568 | 8,824,343 | 8.9 M to 8.8 M (-0.55 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 16,308 | 36,706 | 3,551,924 | 3.6 M to 3.6 M (-0.46 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 37,919 | 85,318 | 6,972,010 | 7 M to 7 M (-0.54 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 48,260 | 108,585 | 8,873,467 | 8.9 M to 8.9 M (-0.54 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 16,021 | 36,047 | 3,568,232 | 3.6 M to 3.6 M (-0.45 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 27,085 | 60,941 | 7,009,929 | 7 M to 7 M (-0.38 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 34,471 | 77,560 | 8,921,727 | 9 M to 8.9 M (-0.38 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.25 | 11,444 | 25,749 | 3,584,253 | 3.6 M to 3.6 M (-0.32 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.34 | 27,164 | 63,466 | 7,037,014 | 7.1 M to 7 M (-0.38 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.34 | 34,572 | 80,774 | 8,956,198 | 9 M to 9 M (-0.38 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.34 | 11,477 | 26,815 | 3,595,697 | 3.6 M to 3.6 M (-0.32 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.30 | 29,214 | 67,192 | 7,064,178 | 7.1 M to 7.1 M (-0.41 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.30 | 37,181 | 85,516 | 8,990,770 | 9 M to 9 M (-0.41 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.30 | 12,344 | 28,391 | 3,607,174 | 3.6 M to 3.6 M (-0.34 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.29 | 41,245 | 94,418 | 7,093,392 | 7.1 M to 7.1 M (-0.58 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.29 | 52,494 | 120,169 | 9,027,951 | 9.1 M to 9 M (-0.58 %) |
Jun 26 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.29 | 17,427 | 39,894 | 3,619,518 | 3.6 M to 3.6 M (-0.48 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 936,839 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 817,541 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 85,962 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 54,385 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 385,962 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,243,423 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,085,085 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,401,003 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 869,667 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 2,013,613 | 0 | 0 | |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | P | 14.00 | 77,539 | 1,085,546 | 832,216 | 754.7 K to 832.2 K (+10.27 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | P | 14.00 | 67,666 | 947,324 | 726,242 | 658.6 K to 726.2 K (+10.27 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | P | 14.00 | 104,795 | 1,467,130 | 1,124,740 | 1 M to 1.1 M (+10.27 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 324,278 | 0 | 754,677 | 430.4 K to 754.7 K (+75.34 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 282,984 | 0 | 658,576 | 375.6 K to 658.6 K (+75.34 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 29,755 | 0 | 647,152 | 617.4 K to 647.2 K (+4.82 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 18,825 | 0 | 402,062 | 383.2 K to 402.1 K (+4.91 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 133,597 | 0 | 1,019,945 | 886.3 K to 1 M (+15.07 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 430,399 | 0 | 430,399 | 0 to 430.4 K |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 375,592 | 0 | 375,592 | 0 to 375.6 K |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 484,944 | 0 | 617,397 | 132.5 K to 617.4 K (+366.13 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 301,027 | 0 | 383,237 | 82.2 K to 383.2 K (+366.17 %) |
Jun 25 2015 | NVLS | Nivalis Therapeuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 696,993 | 0 | 886,348 | 189.4 K to 886.3 K (+368.09 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.35 | 67,475 | 158,499 | 7,134,637 | 7.2 M to 7.1 M (-0.94 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.35 | 85,877 | 201,725 | 9,080,445 | 9.2 M to 9.1 M (-0.94 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.35 | 28,510 | 66,970 | 3,636,945 | 3.7 M to 3.6 M (-0.78 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 65,479 | 157,569 | 7,202,112 | 7.3 M to 7.2 M (-0.90 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 83,338 | 200,545 | 9,166,322 | 9.2 M to 9.2 M (-0.90 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 27,666 | 66,575 | 3,665,455 | 3.7 M to 3.7 M (-0.75 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 52,518 | 126,337 | 7,267,591 | 7.3 M to 7.3 M (-0.72 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 66,842 | 160,795 | 9,249,660 | 9.3 M to 9.2 M (-0.72 %) |
Jun 23 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 22,190 | 53,380 | 3,693,121 | 3.7 M to 3.7 M (-0.60 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 1,447 | 3,589 | 7,320,109 | 7.3 M to 7.3 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 1,842 | 4,568 | 9,316,502 | 9.3 M to 9.3 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 611 | 1,515 | 3,715,311 | 3.7 M to 3.7 M (-0.02 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 76,728 | 189,948 | 7,321,556 | 7.4 M to 7.3 M (-1.04 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 97,654 | 241,752 | 9,318,344 | 9.4 M to 9.3 M (-1.04 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 32,419 | 80,256 | 3,715,922 | 3.7 M to 3.7 M (-0.86 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 19,889 | 47,839 | 7,398,284 | 7.4 M to 7.4 M (-0.27 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 25,313 | 60,885 | 9,415,998 | 9.4 M to 9.4 M (-0.27 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 8,403 | 20,212 | 3,748,341 | 3.8 M to 3.7 M (-0.22 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 43,506 | 104,506 | 7,418,173 | 7.5 M to 7.4 M (-0.58 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 55,372 | 133,009 | 9,441,311 | 9.5 M to 9.4 M (-0.58 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 18,382 | 44,155 | 3,756,744 | 3.8 M to 3.8 M (-0.49 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 35,915 | 86,322 | 7,461,679 | 7.5 M to 7.5 M (-0.48 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 45,710 | 109,864 | 9,496,683 | 9.5 M to 9.5 M (-0.48 %) |
Jun 18 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 15,175 | 36,473 | 3,775,126 | 3.8 M to 3.8 M (-0.40 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 22,973 | 55,144 | 3,790,301 | 3.8 M to 3.8 M (-0.60 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 5,267 | 12,641 | 3,813,274 | 3.8 M to 3.8 M (-0.14 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 1,568 | 3,771 | 3,818,541 | 3.8 M to 3.8 M (-0.04 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 54,370 | 130,510 | 7,497,594 | 7.6 M to 7.5 M (-0.72 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 69,198 | 166,103 | 9,542,393 | 9.6 M to 9.5 M (-0.72 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 12,467 | 29,921 | 7,551,964 | 7.6 M to 7.6 M (-0.16 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.40 | 15,866 | 38,078 | 9,611,591 | 9.6 M to 9.6 M (-0.16 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 3,710 | 8,923 | 7,564,431 | 7.6 M to 7.6 M (-0.05 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.41 | 4,722 | 11,356 | 9,627,457 | 9.6 M to 9.6 M (-0.05 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 44,010 | 106,874 | 7,568,141 | 7.6 M to 7.6 M (-0.58 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 56,012 | 136,020 | 9,632,179 | 9.7 M to 9.6 M (-0.58 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,551 | 44,986 | 7,612,151 | 7.6 M to 7.6 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 23,611 | 57,257 | 9,688,191 | 9.7 M to 9.7 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,551 | 44,986 | 7,630,702 | 7.6 M to 7.6 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 23,611 | 57,257 | 9,711,802 | 9.7 M to 9.7 M (-0.24 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 18,595 | 45,156 | 3,820,109 | 3.8 M to 3.8 M (-0.48 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 7,838 | 19,007 | 3,838,704 | 3.8 M to 3.8 M (-0.20 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.43 | 7,838 | 19,007 | 3,846,542 | 3.9 M to 3.8 M (-0.20 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 67,627 | 166,782 | 7,649,253 | 7.7 M to 7.6 M (-0.88 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 86,071 | 212,268 | 9,735,413 | 9.8 M to 9.7 M (-0.88 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 58,251 | 144,445 | 7,716,880 | 7.8 M to 7.7 M (-0.75 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 74,137 | 183,838 | 9,821,484 | 9.9 M to 9.8 M (-0.75 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.47 | 28,574 | 70,469 | 3,854,380 | 3.9 M to 3.9 M (-0.74 %) |
Jun 15 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.48 | 24,612 | 61,030 | 3,882,954 | 3.9 M to 3.9 M (-0.63 %) |